0000899243-23-001007.txt : 20230105
0000899243-23-001007.hdr.sgml : 20230105
20230105163542
ACCESSION NUMBER: 0000899243-23-001007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230104
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fraser Claire
CENTRAL INDEX KEY: 0001382031
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 23511961
MAIL ADDRESS:
STREET 1: C/O BECTON, DICKINSON AND COMPANY
CITY: FRANKLIN LAKES
STATE: NJ
ZIP: 07465
FORMER NAME:
FORMER CONFORMED NAME: Fraser-Liggett Claire
DATE OF NAME CHANGE: 20061122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-04
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001382031
Fraser Claire
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
5.47
2023-01-04
4
A
0
48000
0.00
A
2033-01-03
Common Stock
48000
48000
D
The option will vest in four equal installments on each anniversary of January 4, 2023 or in full immediately prior to the occurrence of a change in control.
/s/ Thomas J. DesRosier, Attorney-in-fact for Claire Fraser
2023-01-05